Acetylcholinesterase inhibitors (AChEIs) are usually prescribed early in the course of dementia due to Alzheimer’s disease (AD), and patients who respond well may take these drugs for several years (Hernandez et al., 2009). This evidence concerns the gene ACHE and dementia.